These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2148314)

  • 1. Seborrhea and persistent tardive dyskinesia.
    Sandyk R
    Int J Neurosci; 1990 Feb; 50(3-4):223-6. PubMed ID: 2148314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocyte-stimulating hormone in tardive dyskinesia.
    Sandyk R
    Biol Psychiatry; 1989 Jun; 26(2):213-4. PubMed ID: 2567612
    [No Abstract]   [Full Text] [Related]  

  • 3. Melanocyte-stimulating hormone and persistent tardive dyskinesia: a hypothesis.
    Sandyk R
    Int J Neurosci; 1990 Mar; 51(1-2):45-52. PubMed ID: 1979965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic subtypes of tardive dyskinesia: relationship to seborrhea.
    Sandyk R; Pardeshi R
    Int J Neurosci; 1990 Oct; 54(3-4):321-3. PubMed ID: 1979973
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia.
    Sandyk R
    Int J Neurosci; 1990 Aug; 53(2-4):241-2. PubMed ID: 2176181
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of androgens in tardive dyskinesia.
    Sandyk R; Kay SR
    Int J Neurosci; 1991; 56(1-4):215-8. PubMed ID: 1682283
    [No Abstract]   [Full Text] [Related]  

  • 7. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL; Kastin AJ; Beilstein BA; Vento AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocyte-stimulating hormone in tardive dyskinesia.
    Charlton BC
    Biol Psychiatry; 1990 Mar; 27(6):676-8. PubMed ID: 1969754
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL
    Adv Neurol; 1995; 65():211-29. PubMed ID: 7872142
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
    Crayton JW; Smith RC; Klass D; Chang S; Ericksen SE
    Am J Psychiatry; 1977 Jul; 134(7):775-81. PubMed ID: 869055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary associations between motor procedural learning, basal ganglia T2 relaxation times, and tardive dyskinesia in schizophrenia.
    Granholm E; Bartzokis G; Asarnow RF; Marder SR
    Psychiatry Res; 1993 Apr; 50(1):33-44. PubMed ID: 8511222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous dominance and persistent tardive dyskinesia.
    Barr WB; Mukherjee S; Degreef G; Caracci G
    Biol Psychiatry; 1989 Apr; 25(7):826-34. PubMed ID: 2566333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of symptomatology of schizophrenia and tardive dyskinesia.
    Perenyi A; Norman T; Burrows GD
    Eur Neuropsychopharmacol; 1992 Mar; 2(1):51-5. PubMed ID: 1638174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nithsdale schizophrenia survey: III. Handedness and tardive dyskinesia.
    McCreadie RG; Crorie J; Barron ET; Winslow GS
    Br J Psychiatry; 1982 Jun; 140():591-4. PubMed ID: 7104547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laterality of appendicular tardive dyskinesia in chronic schizophrenia.
    Egan MF; Hyde TM; Tirschwell DL; Kleinman JE; Weinberger DR
    Biol Psychiatry; 1992 Jun; 31(11):1098-109. PubMed ID: 1525274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study.
    Yagi G; Takamiya M; Kanba S; Kamijima K
    Keio J Med; 1989 Mar; 38(1):70-2. PubMed ID: 2716220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients.
    Cassady SL; Thaker GK; Tamminga CA
    Psychopharmacol Bull; 1993; 29(2):235-40. PubMed ID: 8290671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.